Records containing: Recurrent Thyroid Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-24A Randomized Phase 2 Study of Single Agent Dabrafenib (BRAFi) vs. Combination Regimen Dabrafenib (BRAFi) and Trametinib (MEKi) in Patients With BRAF Mutated Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2025-07-01Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2025-02-14Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer: A Multicenter Study
-
CLINICAL_TRIALS study record update · 2022-07-25A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) in Patients With Resectable, Primary or Recurrent Head and Neck Cancer
-
CLINICAL_TRIALS study record update · 2019-12-27A Phase 2 Study of Efatutazone, an Oral PPAR Agonist, In Combination With Paclitaxel in Patients With Advanced Anaplastic Thyroid Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-04-25Phase II Study of Sunitinib in Iodine Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of Thyroid With Functional Imaging Correlation
-
CLINICAL_TRIALS study record update · 2015-11-05A Phase I Clinical Trial of Pazopanib in Combination With Escalating Doses of Radioactive 131I in Patients With Well-Differentiated Thyroid Carcinoma Refractory to Radioiodine, Despite Having Some Uptake
-
CLINICAL_TRIALS study record update · 2015-05-15A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children and Young Adults With Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2014-09-01Phase II Study of Decitabine in Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Radioiodine
-
CLINICAL_TRIALS study record update · 2014-08-11Phase II Study of Histone Deacetylase Inhibitor SAHA (Vorinostat) in Patients With Metastatic Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2014-06-25A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2014-05-06A Phase II Trial of 17-Allylaminogeldanamycin (17AAG) in Advanced Medullary and Differentiated Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2014-01-16Phase II Study of BAY 43-9006 in Patients With Metastatic Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2013-12-19A Phase II Study of Single Agent Depsipeptide (FK228) in Radioiodine (RAI)-Refractory Metastatic Non-medullary (Papillary, Follicular, and Hurthle Cell Variants) Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2013-02-28A Phase I Trial of Herceptin and Interleukin-12
-
CLINICAL_TRIALS study record update · 2013-01-14Single Agent ZD-1839 (NSC-715055, IND-61187) in Patients With Advanced Head and Neck Carcinoma or Non-Small Cell Lung Cancer Aged 75 Years and Older (and in a Cohort of Patients 50 Years Old and Younger)
-
CLINICAL_TRIALS study record update · 2012-08-10Phase II Trial of BAY 43-9006 in Patients With Advanced Anaplastic Carcinoma of the Thyroid